279 related articles for article (PubMed ID: 31586081)
21. Everolimus versus sirolimus for angiomyolipoma associated with tuberous sclerosis complex: a multi-institutional retrospective study in China.
Luo C; Zhang YS; Zhang MX; Chen MF; Li Y; Qi L; Li HZ; Zu XB; Cai Y
Orphanet J Rare Dis; 2021 Jul; 16(1):299. PubMed ID: 34217357
[TBL] [Abstract][Full Text] [Related]
22. Application of Everolimus in Preoperative Neoadjuvant Therapy of Tuberous Sclerosis Complex Associated With Renal Angiomyolipoma: A Single-Center Report of 5 Cases.
Guo G; Gu L; Zhang X
Clin Genitourin Cancer; 2019 Dec; 17(6):e1099-e1103. PubMed ID: 31601513
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness and safety of everolimus treatment in patients with tuberous sclerosis complex in real-world clinical practice.
Cockerell I; Christensen J; Hoei-Hansen CE; Holst L; Grenaa Frederiksen M; Issa-Epe AI; Nedregaard B; Solhoff R; Heimdal K; Johannessen Landmark C; Lund C; Nærland T
Orphanet J Rare Dis; 2023 Dec; 18(1):377. PubMed ID: 38042867
[TBL] [Abstract][Full Text] [Related]
24. Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study.
Bissler JJ; Kingswood JC; Radzikowska E; Zonnenberg BA; Belousova E; Frost MD; Sauter M; Brakemeier S; de Vries PJ; Berkowitz N; Voi M; Peyrard S; Budde K
PLoS One; 2017; 12(8):e0180939. PubMed ID: 28792952
[TBL] [Abstract][Full Text] [Related]
25. Long-Term Everolimus Treatment in Individuals With Tuberous Sclerosis Complex: A Review of the Current Literature.
Tran LH; Zupanc ML
Pediatr Neurol; 2015 Jul; 53(1):23-30. PubMed ID: 26092412
[TBL] [Abstract][Full Text] [Related]
26. Safety and Effectiveness of Medical Therapy and Surgical Intervention for Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex.
Wang Z; Zhang W; Fan Y; Zhang X
Cancer Control; 2022; 29():10732748221140266. PubMed ID: 36471546
[TBL] [Abstract][Full Text] [Related]
27. Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2.
Bissler JJ; Budde K; Sauter M; Franz DN; Zonnenberg BA; Frost MD; Belousova E; Berkowitz N; Ridolfi A; Christopher Kingswood J
Nephrol Dial Transplant; 2019 Jun; 34(6):1000-1008. PubMed ID: 30053159
[TBL] [Abstract][Full Text] [Related]
28. Two novel TSC2 mutations in renal epithelioid angiomyolipoma sensitive to everolimus.
Wang T; Xie S; Luo R; Shi L; Bai P; Wang X; Wan R; Deng J; Wu Z; Li W; Xiao W; Wang Y; Chen B; Zhang K; Xing J
Cancer Biol Ther; 2020; 21(1):4-11. PubMed ID: 31597506
[TBL] [Abstract][Full Text] [Related]
29. Treatment of renal angiomyolipoma in tuberous sclerosis complex (TSC) patients.
Brakemeier S; Bachmann F; Budde K
Pediatr Nephrol; 2017 Jul; 32(7):1137-1144. PubMed ID: 27585680
[TBL] [Abstract][Full Text] [Related]
30. Renal angiomyolipoma and tuberous sclerosis complex: long-term safety and efficacy outcomes of Everolimus therapy.
Ruiz Guerrero E; Ledo Cepero MJ; Ojeda Claro AV; Soto Delgado M; Álvarez-Ossorio Fernández JL
Actas Urol Esp (Engl Ed); 2021 May; 45(4):264-272. PubMed ID: 33637375
[TBL] [Abstract][Full Text] [Related]
31. Human TSC-associated renal angiomyolipoma cells are hypersensitive to ER stress.
Siroky BJ; Yin H; Babcock JT; Lu L; Hellmann AR; Dixon BP; Quilliam LA; Bissler JJ
Am J Physiol Renal Physiol; 2012 Sep; 303(6):F831-44. PubMed ID: 22791333
[TBL] [Abstract][Full Text] [Related]
32. Fate of Pediatric Renal Angiomyolipoma During mTOR Inhibitor Treatment in Tuberous Sclerosis Complex.
Wu CQ; Wolf DS; Smith EA
Urology; 2020 May; 139():161-167. PubMed ID: 32081671
[TBL] [Abstract][Full Text] [Related]
33. Everolimus compliance and persistence among tuberous sclerosis complex patients with renal angiomyolipoma or subependymal giant cell astrocytoma.
Song X; Said Q; Tran O; Krueger DA; Bissler J
Curr Med Res Opin; 2019 Jun; 35(6):1103-1110. PubMed ID: 30550347
[TBL] [Abstract][Full Text] [Related]
34. [Rapamycin in the treatment of renal diseases associated with tuberous sclerosis complex].
Dun S; Zou LP; Zhang MN; Wang YY; He W; Chen HM; Hu LY; Chen XQ; Lu Q; Pang LY; Liu LY; Tang LN; Wang B
Zhonghua Er Ke Za Zhi; 2019 Nov; 57(11):852-856. PubMed ID: 31665839
[No Abstract] [Full Text] [Related]
35. Sequential everolimus for angiomyolipoma associated with tuberous sclerosis complex: a prospective cohort study.
Gu L; Peng C; Zhang F; Fang C; Guo G
Orphanet J Rare Dis; 2021 Jun; 16(1):277. PubMed ID: 34127034
[TBL] [Abstract][Full Text] [Related]
36. Concurrent Eosinophilic Solid and Cystic Renal Cell Carcinoma and Angiomyolipoma With Epithelial Cysts in the Setting of Tuberous Sclerosis Complex: A Rare Synchronous Occurrence of 2 Distinct Entities.
Cho WC; Collins K; Mnayer L; Cartun RW; Earle JS
Int J Surg Pathol; 2019 Oct; 27(7):804-811. PubMed ID: 31142207
[TBL] [Abstract][Full Text] [Related]
37. Everolimus-induced near-resolution of giant cardiac rhabdomyomas and large renal angiomyolipoma in a newborn with tuberous sclerosis complex.
Colaneri M; Quarti A; Pozzi M
Cardiol Young; 2016 Jun; 26(5):1025-8. PubMed ID: 27055516
[TBL] [Abstract][Full Text] [Related]
38. Germline mutation of TSC1 or TSC2 gene in Chinese patients with bilateral renal angiomyolipomas and mutation spectrum of Chinese TSC patients.
Jiangyi W; Gang G; Guohai S; Dingwei Y
Aging (Albany NY); 2020 Jan; 12(1):756-766. PubMed ID: 31927531
[TBL] [Abstract][Full Text] [Related]
39. Everolimus in pregnancy: Case report and literature review.
Yamamura M; Kojima T; Koyama M; Sazawa A; Yamada T; Minakami H
J Obstet Gynaecol Res; 2017 Aug; 43(8):1350-1352. PubMed ID: 28557245
[TBL] [Abstract][Full Text] [Related]
40. Assessment of Tuberous Sclerosis Complex Associated With Renal Lesions by Targeted Next-generation Sequencing in Mainland China.
Cai Y; Li H; Zhang Y
Urology; 2017 Mar; 101():170.e1-170.e7. PubMed ID: 28065512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]